Skip to main content

Table 3 Comparison of patients with normal and reduced LVEF as measured by CMR

From: Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach

 

All patients

n = 15

Patients with LVEF ≥ 60%

n = 5

Patients with LVEF <60%

n = 10

p value

LVEF [%]

52 (27 to 70)

65 (61 to 70)

42 (27 to 54)

<0.001

Age [years]

37 (11 to 56)

14 (11 to 26)

42 (23 to 56)

0.004

BMI [kg/m 2 ]

23 (14 to 31)

19 (14 to 23)

23 (22 to 31)

0.048

LV-EDV [ml]

182 (94 to 230)

114 (94 to 212)

192 (129 to 230)

0.047

LV-mass [g]

117 (48 to 163)

70 (48 to 155)

119 (98 to 163)

0.047

LVEDD [mm]

52 (33 to 65)

46 (33 to 57)

55 (47 to 65)

0.09

RVEF [%]

56 (42 to 66)

65 (48 to 66)

54 (42 to 59)

0.10

RV-EDV [ml]

125 (104 to 213)

116 (104 to 213)

134 (104 to 180)

0.79

GWMS

0.19 (0 to 1.06)

0

0.34 (0 to 1.06)

<0.001

LGE [%]

13.0 (0 to 38.0)

0 (0 to 13.0)

17.4 (0 to 38.0)

0.010

Total CK [U/L]

1532 (310 to 28194)

3668 (2570 to 28194)

602 (310 to 3609)

0.006

  1. Results are presented as median in addition to minimal and maximal values; LVEF = left ventricular ejection fraction; BMI = body mass index; LV-EDV = left ventricular end-diastolic volume; LVEDD = left ventricular end-diastolic diameter; RVEF = right ventricular ejection fraction; RV-EDV = right ventricular end-diastolic volume; GMWS = global wall motion score; LGE = late gadolinium enhancement; CK = creatinine kinase.